首页> 外文会议>International symposium for corporate governance >An Empirical Study of Board Composition and RD Expenditure from Chinese Listed Firms
【24h】

An Empirical Study of Board Composition and RD Expenditure from Chinese Listed Firms

机译:中国上市公司董事会组成和研发支出的实证研究

获取原文

摘要

With the data of 790 Chinese listed firms, this paper investigates the relationship between board composition and R&D expenditure. The result shows that board's quality is positive to R&D expenditure. Within the executive directors' proportion from 1/10 to 1/3, or with the opposition of CEO duality, more independent directors result in negative effect on the synergy of R&D decisions or supervising R&D implementation by executive directors, which is inclined to reduce R&D expenditure. For long-term benefit of their firms, more young chairmen of the boards and the second influence director, whose professional background is R&D, product design and marketing, trend to increase more R&D expenditure? The opposition of CEO duality also lowers R&D expenditure.
机译:凭借790家上市公司的数据,本文调查了董事会成分与研发支出之间的关系。结果表明,董事会的质量对研发支出是积极的。在执行董事的比例范围内从1/10到1/3,或者在CEO二元性的反对中,更多独立董事导致执行董事的研发决策协同作用的负面影响,执行董事倾向于减少R&D支出。对于他们公司的长期好处,董事会的更多年轻主席和第二次影响董事,其专业背景是研发,产品设计和营销,趋势增加了更多的研发支出? CEO二元性的反对也降低了研发支出。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号